Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$124,875,066
+$28,779,336 QoQ
Shares Held
104,112
-0.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#342
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. LLY ranks #1 (43.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,875,066 | 104,112 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $96,095,730 | 104,478 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $112,125,673 | 104,334 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $79,559,536 | 104,272 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $80,823,229 | 103,682 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $85,885,554 | 103,989 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $91,873,404 | 119,007 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $107,367,068 | 121,190 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $110,680,894 | 122,248 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $99,231,909 | 127,554 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $73,946,899 | 126,856 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $55,711,660 | 103,721 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $52,549,677 | 112,051 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $31,392,365 | 91,411 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $33,415,459 | 91,339 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,973,490 | 49,400 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,276,346 | 50,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $16,025,265 | 55,960 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $15,457,271 | 55,960 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $12,929,558 | 55,960 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,302,979 | 57,960 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $11,201,727 | 59,960 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,123,646 | 59,960 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $8,875,279 | 59,960 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $11,814,392 | 71,960 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,121,011 | 72,960 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||